CollPlant Biotechnologies (CLGN) Receivables (2017 - 2026)
CollPlant Biotechnologies (CLGN) reported Receivables of $8000.0 for Q1 2026, up 700.0% quarter-over-quarter from $1000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Receivables (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Receivables for 10 years, with the latest figure at $8000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $8000.0 (changed N/A YoY), and the FY2025 full-year result was $1000.0, down 100.0% from the prior year.
- Receivables for Q1 2026 stood at $8000.0, up from $1000.0 in the prior quarter.
- The five-year high for Receivables was $150.0 million in Q4 2024, with the low at $1000.0 in Q4 2025.
- Historically, Receivables has averaged $22.4 million across 5 years, with a median of $2.2 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables surged 112788.89% — and 2025, when it sank 100.0%.
- CollPlant Biotechnologies' Receivables stood at $9.0 million in 2022, then slumped by 55.56% to $4.0 million in 2023, then soared by 3650.0% to $150.0 million in 2024, then slumped by 100.0% to $1000.0 in 2025, then jumped by 700.0% to $8000.0 in 2026.
- The last three Receivables figures came in at $8000.0 (Q1 2026), $1000.0 (Q4 2025), and $150.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 150.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 90.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 323,000.00 |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Dec 31, 2021 | 270.00 Bn |
| Sep 30, 2021 | 135,000.00 |
| Jun 30, 2021 | 277,000.00 |
| Mar 31, 2021 | 174.00 Mn |
| Dec 31, 2020 | 830,000.00 |
| Sep 30, 2020 | 891,000.00 |
| Jun 30, 2020 | 321,000.00 |
| Mar 31, 2020 | 398,000.00 |